Magnetic resonance imaging (MRI) contrast agents are pharmaceuticals used widely in MRI
examinations. Gadolinium‐based MRI contrast agents (GBCAs) are by far the most …

In the last 10 years, the use of intravenous contrast media in magnetic resonance (MR) has
become well‐established clinical practice. Contrast media provide critical additional …

As clinical magnetic resonance (MR) imaging becomes more versatile and more complex, it
is increasingly difficult to develop and maintain a thorough understanding of the physical …

PURPOSE: To assess the safety and diagnostic efficacy of intravenous ferumoxides, a
superparamagnetic iron oxide, for depiction of focal hepatic lesions on magnetic resonance (MR) …

Objectives Calculation of accurate T1 relaxivity (r 1) values for gadolinium-based magnetic
resonance contrast agents (GBCAs) is a complex process. As such, often referenced r 1 …

Dynamic contrast‐enhanced magnetic resonance imaging (DCE MRI) is a method of imaging
the physiology of the microcirculation. A series of recent clinical studies have shown that …

For magnetic resonance, the established class of intravenous contrast media is the
gadolinium-based contrast agents. In the 3 decades since initial approval, these have proven in …

Objectives: Nephrogenic systemic fibrosis (NSF) is a rare acquired disorder that was first
recognized in 1997. Presented is a retrospective review of 6 cases of NSF diagnosed by skin …

Magnetic resonance contrast agents, particularly the gadolinium-based agents, are extremely
safe and lack the nephrotoxicity associated with iodinated contrast media. Currently, …

A device for gating the acquisition of magnetic resonance images with chest wall motion was
developed, and the effects of respiratory gating upon image quality were studied. Images of …